Bernhard Ludvik
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 109 publications
Semaglutide in peripheral artery disease and diabetes by baseline disease severity and age: the STRIDE trial.
Journal: European heart journal
Published: March 04, 2026
Design, rationale, and baseline characteristics of the dapagliflozin in haemodialysis (DAPA-HD) trial.
Journal: ESC heart failure
Published: February 03, 2026
Obesity and type 2 diabetes mellitus (Update 2026)
Journal: Wiener klinische Wochenschrift
Published: January 14, 2026
Antihyperglycemic treatment of type 2 diabetes mellitus (Update 2026)
Journal: Wiener klinische Wochenschrift
Published: January 02, 2026
Hospital diabetes management (Update 2026)
Journal: Wiener klinische Wochenschrift
Published: January 02, 2026
Response to STRIDE: semaglutide in peripheral artery disease and type 2 diabetes - Authors' reply.
Journal: Lancet (London, England)
Published: December 20, 2025
Diabetes education and counseling in adult patients with diabetes (Update 2026)
Journal: Wiener klinische Wochenschrift
Published: December 09, 2025
Nutrition recommendations for people with diabetes (Update 2026)
Journal: Wiener klinische Wochenschrift
Published: November 14, 2025
Prevalence of Strongyloides stercoralis in haemodialysis patients in Vienna.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: September 26, 2025
Diagnostics and treatment of type 1 diabetes mellitus (Update 2026)
Journal: Wiener klinische Wochenschrift
Published: September 02, 2025
Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease : Austrian Society of Gastroenterology and Hepatology (ÖGGH), Austrian Society of Diabetology (ÖDG), Austrian Society of Obesity (ÖAG).
Journal: Wiener klinische Wochenschrift
Published: August 25, 2025
Last Updated: 09/26/2026